Laboratory Automation and Smart Reagent Supply Chain Market Report 2026

The laboratory automation and smart reagent supply chain market size has grown rapidly in recent years. It will grow from $1.52 billion in 2025 to $1.69 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to manual laboratory processes limiting operational efficiency, increasing demand for high-throughput drug discovery, growth in pharmaceutical and biotechnology research activities, rising need for accurate sample tracking and documentation, expansion of clinical diagnostic laboratory networks.

The laboratory automation and smart reagent supply chain market size is expected to see rapid growth in the next few years. It will grow to $2.6 billion by 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to increasing adoption of fully automated laboratory ecosystems, rising demand for real-time reagent inventory monitoring systems, growing integration of ai-based decision support in labs, expansion of personalized medicine and genomics research, advancements in robotic laboratory instrumentation and connectivity. Major trends in the forecast period include increasing adoption of ai-driven laboratory workflow optimization, rising integration of robotic sample preparation systems, growing deployment of iot-enabled reagent tracking solutions, expansion of cloud-based laboratory information management systems, increasing use of predictive analytics for reagent consumption and inventory planning.

The growing focus on personalized medicine is expected to propel the growth of the laboratory automation and smart reagent supply chain market going forward. Personalized medicine involves tailoring medical treatments and laboratory diagnostics based on an individual’s genetic, proteomic, and metabolic profile to achieve optimized therapeutic outcomes. The increasing emphasis on personalized medicine is contributing to market growth, driven by advancements in genomics, expanding availability of patient-specific biomarker data, and rising demand for targeted therapeutic approaches. Laboratory automation and smart reagent supply chain systems are supporting personalized medicine by enabling high-throughput, precise, and reproducible sample processing, efficient reagent management, and integrated laboratory workflows, thereby enhancing diagnostic accuracy and improving patient care outcomes. For instance, in February 2024, according to the Personalized Medicine Coalition, a U. S. -based nonprofit organization, personalized medicines accounted for more than one-third of new FDA drug approvals in 2023, up from 28% in 2022, marking the fourth consecutive year of growth. Therefore, the growing focus on personalized medicine is driving the growth of the laboratory automation and smart reagent supply chain market.

Leading companies operating in the laboratory automation and smart reagent supply chain market are focusing on advancing modular and integrated robotics solutions such as automated liquid-handling workstations with no-code programming interfaces to meet the rising demand for efficient, high-throughput, and reproducible laboratory operations. Automated liquid-handling workstations combine robotic pipetting with intuitive software controls, enabling scientists to perform complex sample preparation, reagent dispensing, and assay workflows with improved consistency, accuracy, and throughput. For example, in September 2024, Opentrons Labworks Inc., a US-based lab automation and robotics company, launched the Opentrons Flex Prep, an automated liquid-handling system featuring no-code touchscreen programming for workflow setup and a modular deck supporting various tube and plate formats. The system allows expansion with additional modules for advanced protocols such as magnetic bead clean-ups and next-generation sequencing library preparation. It significantly reduces hands-on time, minimizes operator errors, and enables rapid adaptation to diverse laboratory workflows, demonstrating how automation innovations are enhancing efficiency and scalability in laboratory operations.

In December 2023, Hudson Robotics and Art Robbins Instruments, a US-based laboratory automation and instrumentation company, acquired Tomtec Inc. for an undisclosed amount. Through this acquisition, the company aims to enhance automated liquid handling capabilities and accelerate the development of integrated solutions for bioanalytical sample preparation workflows. Tomtec Inc. is a US-based company specializing in automated liquid handling instruments used for sample preparation and mass spectrometry applications.

Major companies operating in the laboratory automation and smart reagent supply chain market are Hitachi High‑Tech Corporation, F. Hoffmann‑La Roche Ltd, Thermo Fisher Scientific Inc., Danaher Corporation, GE Healthcare Ltd., Parker‑Hannifin Corporation, Corning Incorporated, Rockwell Automation Inc., Illumina Inc., Mettler‑Toledo International Inc., Sartorius AG, PerkinElmer Inc., Getinge AB, Bruker Corporation, Bio‑Rad Laboratories Inc., Bioengineering AG, Eppendorf SE, Tecan Group Ltd., Agilent Technologies Inc., Hamilton Company, Pierre Guérin SAS, Genedata AG, Inscripta Inc., INFORS HT (WTZ) AG, Flownamics Inc., ILS Automation GmbH, PendoTECH Inc., Synthace Ltd.

North America was the largest region in the laboratory automation and smart reagent supply chain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the laboratory automation and smart reagent supply chain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the laboratory automation and smart reagent supply chain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The laboratory automation and smart reagent supply chain market consists of revenues earned by entities by providing services such as automated liquid handling systems, robotic sample preparation platforms, laboratory workflow management software, integrated laboratory informatics solutions, smart reagent tracking, inventory management services, and cloud-based laboratory management platforms. The market value includes the value of related goods sold by the service provider or included within the service offering. The laboratory automation and smart reagent supply chain market also includes sales of automated analyzers, robotic arms, sample storage and transport systems, smart reagent dispensers, sensors, and IoT-enabled laboratory instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream laboratories, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.